{"DataElement":{"publicId":"65038","version":"3","preferredName":"Positive Malignant Neoplasm Biopsy Specimen Percentage Value","preferredDefinition":"a measurement by percentage indicating the amount of malignant cells contained in a sample of tissue or body fluid collected for pathologic examination.","longName":"PO_MN_BX_SPE_PTG_VAL","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2192183","version":"1","preferredName":"Positive Malignant Neoplasm Biopsy Specimen","preferredDefinition":"information related to presence of malignant tumor or atypical neoplastic cells in a sample of tissue or body fluid removed from the living body for pathologic examination.","longName":"POS_MAL_NEO_BX_SPEC","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2206802","version":"1","preferredName":"Positive Malignant Neoplasm","preferredDefinition":"Involving advantage or good.:A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.  Malignant neoplasms usually metastasize to distant anatomic sites and may recur after excision.  The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin's and non-Hodgkin's lymphomas, leukemias, melanomas, and sarcomas. -- 2004","longName":"C25246:C9305","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Positive","conceptCode":"C25246","definition":"Involving advantage or good.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-051C-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2453799","version":"1","preferredName":"Biopsy Specimen","preferredDefinition":"Removal and pathologic examination of specimens in the form of small pieces of tissue from the living body.:Specimen; a bit of tissue or blood or urine that is taken or used for research purposes.","longName":"C15189:C19157","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Biopsy","conceptCode":"C15189","definition":"The removal of tissue specimens or fluid from the living body for microscopic examination, performed to establish a diagnosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Specimen","conceptCode":"C19157","definition":"A part of a thing, or of several things, taken to demonstrate or to determine the character of the whole, e.g. a substance, or portion of material obtained for use in testing, examination, or study; particularly, a preparation of tissue or bodily fluid taken for examination or diagnosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0E070B71-8F2C-1732-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-03-07","endDate":null,"createdBy":"PWEST","dateCreated":"2006-03-07","modifiedBy":"ONEDATA","dateModified":"2006-03-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008547","version":"1","preferredName":"Specimen Characteristics","preferredDefinition":"attributes of a patient's laboratory sample, including the source, condition, and fixative.","longName":"SPEC_CHAR","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22908C4-638F-4A74-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E9014736-7B17-1433-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-03-06","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-11-16","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"update for EVS terminology and consistency with related CDEs","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2019134","version":"1","preferredName":"Malignant Neoplasm Specimen Percentage Value","preferredDefinition":"A percentage value expressing presence of malignant cells in a sample of tissue or body fluid.","longName":"MAL_NEO_SPEC_PTG_VAL","context":"NCI Standards","contextVersion":"1","type":"Non-enumerated","dataType":"NUMBER","unitOfMeasure":"%","minLength":"1","maxLength":"4","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[],"ConceptualDomain":{"publicId":"2008547","version":"1","preferredName":"Specimen Characteristics","preferredDefinition":"attributes of a patient's laboratory sample, including the source, condition, and fixative.","longName":"SPEC_CHAR","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22908C4-638F-4A74-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2208119","version":"1","preferredName":"Percentage Value","preferredDefinition":"Percentage; a fraction or ratio with 100 understood as the denominator.:A numerical quantity measured or assigned or computed.","longName":"C25613:C25712","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Percentage","conceptCode":"C25613","definition":"A fraction or ratio with 100 understood as the denominator.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Value","conceptCode":"C25712","definition":"A numerical quantity measured or assigned or computed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-3E46-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Standard","id":"C34B81CA-187E-66B7-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-11-16","endDate":null,"createdBy":"MWHITE","dateCreated":"2003-07-25","modifiedBy":"HARTLEYG","dateModified":"2018-06-06","changeDescription":"8/24/17 tt transferred context, added registration status and CSI per Round 5 finalization task.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008587","version":"2","longName":"Type of Disease","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811910","version":"1","longName":"Prostate","context":"CTEP"}]},{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811953","version":"1","longName":"Disease Description","context":"CTEP"}]},{"publicId":"2008594","version":"2.31","longName":"Trial Type Usages (CDE Disease Committees)","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811937","version":"1","longName":"Pathology Prostate","context":"CTEP"}]},{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2812367","version":"1","longName":"caBIG","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]},{"publicId":"2183535","version":"1","longName":"Clinical Trial Mgmt Systems","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2812625","version":"1","longName":"CTMS C3D Adopter Sites","context":"NCIP"},{"publicId":"2812726","version":"1","longName":"U Nebraska Med Center","context":"NCIP"}]}],"AlternateNames":[{"name":"caBIG","type":"USED_BY","context":"NCIP"}],"ReferenceDocuments":[{"name":"Percent of Cancer in Biopsy","type":"Preferred Question Text","description":"Percent of Cancer in Biopsy","url":null,"context":"CTEP"},{"name":"COMMENT_504","type":"COMMENT","description":"Add instruction to form: %","url":null,"context":"CTEP"},{"name":"CRF Text","type":"Alternate Question Text","description":"Biopsy Cancer Present Percentage","url":null,"context":"CTEP"}],"origin":"CTEP CDE Committee","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"C34C6F2A-13CB-6793-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-07-25","endDate":null,"createdBy":"MWHITE","dateCreated":"2003-07-25","modifiedBy":"REEVESD","dateModified":"2014-02-19","changeDescription":"ISO11179 Compliance","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}